Guntur Doctors Successfully Treat Drug-Resistant Bone Infection with Phage Therapy

Quick Summary

• Doctors at SHRI Hospital, Guntur, successfully treated a 72-year-old woman from Bapatla suffering from a chronic multidrug-resistant bone and joint infection caused by Acinetobacter baumannii.
• teh infection had resisted all available antibiotics for six months before the patient was admitted in critical condition in January.
• A medical team led by Dr. K. Kalyan Chakravarthy collaborated with Prof. Gopal nath of Banaras Hindu University to use bacteriophage therapy-viruses that target bacteria-to treat the patient.
• Orthopaedic surgeon dr. Raviteja Y. and anaesthetist Dr.Ramakrishna K also assisted in the procedure.
• Phage therapy, which predates antibiotics, is becoming essential as antimicrobial resistance increases globally; purified bacteriophages are considered safe under “compassionate use” protocols.
• The patient has experienced no recurrence of infection over six months post-treatment.

Image Details:
Photo Credit: T VIJAY KUMAR | Image features dr. K. Kalyan Chakravarthy

Indian Opinion Analysis

The success of this case highlights the burgeoning importance of bacteriophage therapy as a solution to multidrug-resistant infections, a growing concern in modern healthcare systems worldwide, including India’s robust but overstretched medical infrastructure. Multidrug resistance threatens meaningful setbacks in treating common infections and could exacerbate public health challenges if conventional antibiotics fail.

India’s expertise demonstrated through collaboration between SHRI Hospital and Banaras Hindu University underscores its leadership potential in developing option therapies like phage treatment for antibiotic-resistant pathogens-a field gaining renewed attention across global medical research hubs like the UK and U.S.

Strategically expanding clinical trials domestically could reduce dependence on global studies while addressing India’s unique challenges with antimicrobial resistance due to widespread self-medication practices or inadequate regulation over antibiotic usage.

Such advancements may offer hope for more affordable treatments under compassionate use protocols while positioning India at the forefront of biotherapeutic innovation against life-threatening infections affecting vulnerable populations.

For further details: Read More